Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqCM:RMR
NasdaqCM:RMRReal Estate

Discovering US Market's Hidden Gems: 3 Promising Small Caps

In the last week, the United States market has stayed flat, but it has risen by 28% over the past year with earnings forecasted to grow by 16% annually. In this dynamic environment, identifying promising small-cap stocks can offer unique opportunities for investors seeking growth potential beyond well-known large-cap companies.
NYSE:BVN
NYSE:BVNMetals and Mining

Top Dividend Stocks To Consider In May 2026

The United States market has remained flat over the last week, but it has experienced a notable 28% rise over the past 12 months, with earnings forecasted to grow by 16% annually. In these conditions, dividend stocks that offer consistent payouts and have strong fundamentals can be an appealing choice for investors seeking stability and income.
XTRA:DBK
XTRA:DBKCapital Markets

Should Record Q1 Profit and Strong Private Banking Inflows Require Action From Deutsche Bank (XTRA:DBK) Investors?

In late April 2026, Deutsche Bank reported record first-quarter results, with net interest income of €4,204 million and net income of €2,118 million, while also issuing a broad suite of senior, unsecured Eurobond and Eurodollar notes across fixed, variable, and zero-coupon structures. An especially material development was the private banking arm’s profit before tax rising 39% and assets under management increasing 10% year-on-year, underpinned by strong net inflows that highlight robust...
TSE:4523
TSE:4523Pharmaceuticals

How Investors Are Reacting To Eisai (TSE:4523) Leaning On Leqembi After Fresh Sales Update

Eisai Co., Ltd. recently reported preliminary first-quarter 2026 sales of ¥26.2 billion, alongside fiscal 2025 revenue of ¥88 billion from its Alzheimer’s drug Leqembi, underscoring the scale of its neurology operations. This combination of strong Leqembi revenue and fresh quarterly sales data highlights how Eisai’s neuroscience focus is increasingly anchored by a single high-impact Alzheimer’s therapy. Next, we’ll examine how Leqembi’s ¥88 billion revenue contribution and the latest...
NYSE:FUBO
NYSE:FUBOInteractive Media and Services

Does FuboTV’s (FUBO) Packed Sports Slate Reveal Durable Streaming Moat Or Just Promotional Heat?

In recent days, Fubo has been highlighted as the live-streaming platform for a slate of major sports events, ranging from MLB matchups to Serie A fixtures and the Manchester United vs Liverpool clash in Canada, as well as WNBA preseason action. This clustering of high-profile broadcasts across different leagues and regions underscores Fubo’s growing role as a go-to destination for live sports streaming without traditional cable. We’ll now explore how this expanded live sports coverage,...
NYSE:RLJ
NYSE:RLJHotel and Resort REITs

How Investors Are Reacting To RLJ Lodging Trust (RLJ) Sliding From Profit To Loss On Higher Revenue

RLJ Lodging Trust has reported first-quarter 2026 results, with sales rising to US$275.26 million and total revenue to US$339.98 million, but shifting from a US$3.36 million net profit a year earlier to a small US$0.141 million net loss. This move into a slight loss, despite higher revenue and against a backdrop of urban market cost pressures, raises questions about how effectively the company is converting its top-line growth into sustainable profitability. We’ll now examine how this move...
NasdaqGM:KDK
NasdaqGM:KDKAuto Components

Assessing Kodiak AI (KDK) Valuation After Mixed Short And Long Term Share Price Performance

Kodiak AI stock: what recent performance tells you Kodiak AI (KDK) has drawn attention after a mixed stretch in the stock, with a small single day decline, a drop over the past week, a gain over the past month, and weaker returns over the past year. See our latest analysis for Kodiak AI. With the share price at $8.35, Kodiak AI’s 30 day share price return of 12.53% contrasts with a year to date share price return of 22.90% and a 1 year total shareholder return of 25.84%. This suggests recent...
NYSE:ARW
NYSE:ARWElectronic

Do Earnings Revisions And Vanguard’s Stake Shift the Bull Case For Arrow Electronics (ARW)?

In recent weeks, Arrow Electronics has attracted attention as earnings estimates edged higher and research firm Zacks assigned the stock a Rank #2 (Buy) with a Momentum Style Score of B, alongside new SEC filings showing Vanguard entities holding passive stakes above 5% of outstanding shares as of March 31, 2026. This combination of incremental earnings upgrades, favorable momentum indicators, and sizeable passive institutional ownership highlights shifting sentiment toward Arrow’s...
NYSE:PMT
NYSE:PMTMortgage REITs

A Look At PennyMac Mortgage Investment Trust’s Valuation After Launching The Team USA Athlete Mortgage Program

Why the new Team USA program matters for PennyMac Mortgage Investment Trust (PMT) PennyMac Mortgage Investment Trust (PMT) is in focus after launching the Welcome Home: Athlete Mortgage Program with PennyMac Financial Services. The program targets Team USA athletes with tailored lending support, benefits, and education. See our latest analysis for PennyMac Mortgage Investment Trust. The Athlete Mortgage Program arrives as PMT’s share price trades at US$12.33, with a 30 day share price return...
NYSE:CUZ
NYSE:CUZOffice REITs

Impairment-Driven Loss Amid Strong Leasing Might Change The Case For Investing In Cousins Properties (CUZ)

Cousins Properties reported first-quarter 2026 results on April 29, 2026, with revenue rising to US$263.11 million while moving from net income of US$20.9 million a year earlier to a net loss of US$24.86 million, largely due to a US$36.6 million impairment on its One Eleven Congress asset. Despite the accounting loss, the company showed resilient operations with strong Sun Belt leasing activity, higher occupancy, an increase in funds from operations guidance, and an expanded US$500 million...
SEHK:1093
SEHK:1093Pharmaceuticals

How CSPC’s Oncology Pipeline Milestones and Governance Update Will Impact CSPC Pharmaceutical Group (SEHK:1093) Investors

CSPC Pharmaceutical Group recently reported several oncology milestones, including U.S. FDA clearance for SYH2095 clinical trials and strong Phase Ib/III results for its sirolimus injection HB1901 in advanced malignant PEComa, alongside proposed updates to its articles of association to support hybrid and virtual shareholder meetings. With first-in-class epigenetic and novel sirolimus-based therapies progressing and antibody-drug conjugate SYS6051 entering trials in both the U.S. and China,...
NYSE:SJM
NYSE:SJMFood

The Bull Case For J. M. Smucker (SJM) Could Change Following Divergent Analyst Calls And Vanguard Stake Learn Why

In recent days, several major banks updated their views on J. M. Smucker, with Morgan Stanley and Stifel reiterating cautious stances while BTIG began coverage with a more optimistic outlook focused on the company’s coffee business and changing consumer landscape. At the same time, Vanguard disclosed a sizeable passive ownership stake of more than 7 million shares, underlining continued institutional interest in the stock despite differing analyst opinions on its prospects. We’ll now look at...
NasdaqGS:SBRA
NasdaqGS:SBRAHealth Care REITs

A Look At Sabra Health Care REIT (SBRA) Valuation After Its Recent Share Price Momentum

Performance snapshot and why Sabra might be on your radar Sabra Health Care REIT (SBRA) has quietly put together a solid run, with the stock up about 2.5% over the past month and roughly 11% in the past 3 months. For income focused investors watching healthcare real estate, that move, combined with a market value of about US$5.1b and reported annual revenue of US$815.664m, may prompt a closer look at what is driving sentiment. See our latest analysis for Sabra Health Care REIT. At a share...
NYSE:WCN
NYSE:WCNCommercial Services

Waste Connections’ Acquisition Push, AI Pricing And Capital Returns Might Change The Case For Investing In WCN

In the first quarter of 2026, Waste Connections reported higher sales of US$2,370.63 million but lower net income of US$219.34 million year over year, while maintaining its regular US$0.35 quarterly dividend and continuing share repurchases under its existing buyback program. Management also signaled an “above-average” year for acquisitions, citing a robust pipeline including about US$100 million in annualized revenue from deals expected to close by early third quarter, alongside early gains...
NasdaqCM:RGTI
NasdaqCM:RGTISemiconductor

Quantum Computing Stocks For 2026 If You Expect Real Cash Flows

Quantum computing is moving from theory to tangible products at the same time as investors are dealing with higher inflation, elevated bond yields and energy related uncertainty. In this setting, some prefer themes where long term research and intellectual property matter as much as near term growth. The Quantum Computing Stocks screener focuses on companies working on hardware, software and research around quantum algorithms and superconducting qubits. It can help you quickly narrow a...
NasdaqGS:NEOG
NasdaqGS:NEOGMedical Equipment

A Look At Neogen’s (NEOG) Valuation As Recent Share Price Move Highlights Mixed Return History

Neogen (NEOG) came into focus after a recent move in its share price, with the stock last closing at $9.53. For investors, that price helps frame the discussion around value and expectations. See our latest analysis for Neogen. That recent move sits within a mixed picture, with a strong year to date share price return of 36.14% and a 1 year total shareholder return of 68.97% contrasting with a 3 year total shareholder return of 44.46% and a 5 year total shareholder return of 79.38%. This...
NYSE:BXP
NYSE:BXPOffice REITs

Is Boston Properties (BXP) Offering Value After Recent Share Price Swings?

Wondering whether BXP at around US$59.37 is offering value or just value traps? This article breaks down what the current price might really mean for you. The stock has recently shown mixed returns, with a 2.3% gain over the last week and 14.7% over the last month, set against a year to date return of a 12.5% decline and a 1 year return of a 3.8% decline. Over the longer term, the picture is uneven, with a 37.9% gain across 3 years contrasted by a 29.0% decline over 5 years. This can leave...
NasdaqGS:GLXY
NasdaqGS:GLXYCapital Markets

If Bitcoin And AI Both Win These Cryptocurrency Stocks Could Surprise

Crypto and blockchain are back in focus as investors look for assets that can handle higher energy costs, sticky inflation risks, and shifting central bank plans. With AI-related demand supporting parts of global trade and payment systems under pressure from geopolitical tension, the broader digital infrastructure story is still evolving. The Top Cryptocurrency and Blockchain Stocks screener cuts through the noise by highlighting companies directly linked to this theme, without relying on...
NasdaqGS:COHU
NasdaqGS:COHUSemiconductor

Cohu (COHU) Valuation Check After Upgraded 2026 Outlook And Strong AI And High Performance Computing Momentum

Cohu (COHU) gave investors fresh data to work with after first quarter 2026 results, combining higher semiconductor test demand tied to AI and high performance computing with updated guidance and a larger opportunity pipeline. See our latest analysis for Cohu. Those stronger AI and high performance computing headlines have arrived alongside a sharp re-rating, with an 85.25% year to date share price return and a very large 1 year total shareholder return, even after a recent 3.72% 1 day...
NasdaqGM:MAAS
NasdaqGM:MAASInsurance

Assessing Maase (MAAS) Valuation After A Sharp Multi‑Month Share Price Surge

Recent price action and business snapshot Maase (MAAS) has drawn investor attention after a 63% share price move over the past month and 58% over the past 3 months, prompting a closer look at its current fundamentals. The company provides technological intelligence and capital investment services in China through a technology-driven independent financial service platform and independent wealth management services. It reports revenue of CN¥3.483 and a net loss of CN¥1.775. See our latest...
TSX:EQX
TSX:EQXMetals and Mining

Equinox Gold (TSX:EQX) Valuation Check As Q1 Strength, Valentine Ramp Up And New Dividend Draw Attention

Equinox Gold (TSX:EQX) is back in focus after strong Q1 production, a successful Valentine mine ramp up, significant debt reduction, and a new dividend, all announced ahead of its May 6 financial results. See our latest analysis for Equinox Gold. Despite a recent 6.4% 30 day share price decline and a 7.6% 90 day share price pullback to around CA$19.03, the 1 year total shareholder return of 111.4% and 3 year total shareholder return of about 1.5x suggest momentum has been strong. Recent Q1...